Highlights

  • IperionX Limited (ASX:IPX) continued ramping up titanium powder production at its Virginia manufacturing facility, targeting an annualised production capacity of approximately 200 tonnes by the end of calendar 2026.
  • US government support included a US$47.1 million obligated funding award and an earlier US$12.7 million award, alongside additional defence-related manufacturing and development programmes.
  • IperionX reported US$35.2 million in cash at 30 June 2026 and subsequently raised approximately US$50 million before costs through a US public offering to support its expansion plans.

How does an early-stage materials company turn promising technology into dependable industrial output?

For IperionX Limited (ASX:IPX), the answer involves expanding titanium manufacturing capacity in Virginia, progressing customer qualification programmes and securing government support for domestic critical materials production.

The company's June 2026 quarterly report, released on 30 July 2026, highlighted continued development of titanium powder manufacturing and downstream components.

Subsequent announcements regarding US Army programmes and its GenX production technology provided further evidence of operational progress.

However, increasing manufacturing capacity does not automatically establish sustainable commercial production or profitability.

The company's longer-term performance will depend on production reliability, customer adoption, manufacturing economics and access to financing.

What IperionX Does

IperionX is an ASX- and Nasdaq-listed titanium metal and critical materials company developing production and processing operations in the United States.

The company uses proprietary technologies, including Hydrogen Assisted Metallothermic Reduction (HAMR), to manufacture titanium powder from titanium feedstocks, including recycled materials.

IperionX aims to reduce the cost, energy requirements and environmental impact associated with conventional titanium production.

However, the extent of these potential advantages at sustained industrial scale remains dependent on operating performance and commercial validation.

Titanium is valued for its strength-to-weight ratio and corrosion resistance, making it relevant to aerospace, defence, automotive, medical and industrial applications.

IperionX also owns critical minerals assets in Tennessee, supporting its longer-term strategy to establish an integrated domestic supply chain.

The company remains in a manufacturing expansion phase, with future earnings dependent on scaling production and converting customer programmes into recurring commercial revenue.

Progress in Virginia

IperionX continued operating its Virginia titanium manufacturing facility on a 24-hour production schedule during the June 2026 quarter.

Its HAMR production systems remained in the ramp-up phase, supporting customer qualification programmes, titanium powder requirements and component manufacturing.

The company reported that its titanium powder production continued to meet or exceed relevant Grade 5 quality parameters.

Nevertheless, production volumes were temporarily affected by furnace downtime and maintenance.

Management subsequently reported a return to the regular ramp-up schedule, with sufficient powder available for downstream manufacturing activities.

IperionX continued targeting approximately 200 tonnes per annum of titanium powder production capacity by the end of calendar 2026.

This remained a target rather than an achieved production rate.

Future output will depend on equipment reliability, process optimisation and sustained operational performance.

GenX Technology Advances Beyond Initial Development

IperionX's next-generation GenX platform represents an additional opportunity to improve titanium manufacturing efficiency.

The technology applies the company's HAMR process through a continuous production system rather than relying exclusively on batch processing.

In September 2026, IperionX announced successful validation of continuous titanium production through initial production campaigns at its Virginia research and development facility.

The company reported processing more than 500 kilograms of titanium powder during four continuous runs.

Testing also demonstrated improvements in material throughput and resource consumption compared with its existing batch HAMR process.

These results support further development of the platform, although they do not establish commercial profitability for a full-scale GenX production line.

The company's next steps include process optimisation, integration into a complete powder production system and engineering assessments for larger-scale manufacturing.

Turning Titanium Powder Into Finished Components

Producing titanium powder represents only one component of IperionX's manufacturing strategy.

The company is also developing equipment and processes to convert powder into finished or near-net-shape titanium components.

During May 2026, a 300-tonne, six-axis powder metallurgy press completed commissioning at the Virginia facility.

According to IperionX, the equipment increased its existing powder metallurgy capacity approximately threefold.

The company also progressed installation and commissioning of additional sintering equipment intended to expand downstream manufacturing capacity.

These developments support the production of more complex titanium components for customer testing and potential commercial applications.

However, the financial contribution from additional equipment will depend on utilisation, customer qualification and production efficiency.

Defence, Automotive and Industrial Customer Programmes

IperionX continued advancing several customer programmes during 2026.

Independent testing undertaken in connection with the US Army's DEVCOM Ground Vehicle Systems Center assessed titanium alloy fasteners manufactured using the company's processes.

The company reported that the fasteners exceeded the torque-to-yield performance of SAE Grade 8 steel in the specified tests.

Following the June quarter, IperionX received an additional US Army purchase order for prototype titanium fasteners intended for military vehicle applications.

Other customer programmes included titanium pump impeller prototypes for Carver Pump, automotive components for Ford and development work involving titanium track pins.

The company also advanced titanium powder samples for qualification across industrial and advanced manufacturing applications.

These activities demonstrate progress in customer engagement.

However, prototype testing and qualification programmes should not be interpreted as confirmed high-volume commercial supply agreements.

Recurring revenue will depend on successful validation, customer approvals and subsequent purchase commitments.

Additional US Army Manufacturing Support

US government-related development programmes remain central to IperionX's expansion strategy.

In August 2026, the company announced a second US Army task order under its existing Small Business Innovation Research Phase III contracting framework.

The programme supports further development of titanium manufacturing capabilities, including continuous processing technologies.

This adds to the company's existing defence-related work involving titanium fasteners, military components and production capacity expansion.

The additional task order demonstrates further government engagement with IperionX's manufacturing technology.

However, individual task orders and programme awards must be distinguished from the maximum value available under broader contracting arrangements.

The existence of a contracting framework does not guarantee that the full potential contract value will become revenue.

The Role of US Government Funding

US government support remains an important component of IperionX's financing and production expansion plans.

The company's June 2026 quarterly report identified a fully obligated US$47.1 million award under the Industrial Base Analysis and Sustainment programme.

This funding supports a planned titanium manufacturing expansion pathway.

IperionX also referred to an earlier US$12.7 million award under the Defense Production Act Title III programme.

At 30 June 2026, the company reported US$37.1 million in remaining obligated reimbursable government funding.

This included approximately US$2.9 million of eligible programme expenditure already incurred but awaiting reimbursement.

The company also received approximately 290 metric tonnes of titanium scrap from the US government at no cost.

These arrangements provide manufacturing support and access to strategic resources.

However, reimbursement arrangements remain subject to programme conditions, documentation and applicable approval processes.

Government funding should therefore not be treated as unrestricted cash already received.

Cash Position and Additional Funding

IperionX reported cash of US$35.2 million at 30 June 2026.

The company continued investing in titanium manufacturing, equipment expansion, customer development and research activities during the quarter.

In July 2026, IperionX priced an underwritten US public offering of approximately US$50 million in gross proceeds.

The offering involved American depositary shares priced at US$21.98 each.

IperionX also received a US$2.4 million government reimbursement after the June quarter.

Following these developments, the company reported a pro forma cash position of approximately US$84 million, incorporating net offering proceeds and the reimbursement.

This pro forma figure should be distinguished from its actual 30 June cash balance.

Although the additional capital supports planned investment, equity issuance increases the number of securities outstanding and can dilute existing shareholders.

Further financing needs will depend on future expenditure, operating cash generation, government reimbursements and commercial revenue development.

Titan Critical Minerals Project

IperionX also continued advancing its Titan Critical Minerals Project in Tennessee.

During June 2026, the company completed a Definitive Feasibility Study assessing the proposed development of the project.

The study estimated an after-tax net present value at an 8% discount rate of US$813 million and an after-tax internal rate of return of 39.4%.

It also projected an after-tax payback period of 3.6 years and approximately US$1.9 billion in cumulative after-tax free cash flow over an initial 14-year mine plan.

These figures represent feasibility-study projections rather than achieved financial results.

They depend on assumptions concerning commodity prices, development costs, production, financing and operating performance.

The project is intended to produce critical mineral products, including titanium minerals, zircon and heavy rare earth concentrate.

Future development will depend on funding, permitting requirements, construction execution and commercial market conditions.

Atlas Acquisition Expands Critical Minerals Strategy

IperionX completed a strategic acquisition of adjacent critical minerals property and infrastructure assets in Tennessee in July 2026.

The acquisition was associated with consideration of approximately US$3 million.

The acquired assets included mineral-bearing stockpiles, pre-stripped mineralisation and infrastructure relevant to future development planning.

IperionX identified potential advantages from combining these assets with its Titan project.

The company is progressing additional technical and economic work to assess potential integration benefits.

An integrated assessment was targeted for completion towards the end of calendar 2026.

However, expected development efficiencies and project economics remain subject to further technical evaluation.

Competitive Position and Commercial Opportunity

The United States continues seeking greater resilience in critical minerals and defence-related manufacturing supply chains.

Titanium is important to several advanced industries, including aerospace, military equipment, transportation and precision manufacturing.

IperionX aims to participate in this market through domestic production, proprietary processing technology and government-supported expansion.

Its strategy combines titanium powder manufacturing, component production and upstream critical minerals development.

Successful execution could strengthen the company's position within selected domestic supply chains.

However, commercial competitiveness will depend on product quality, manufacturing costs, delivery reliability and the ability to secure recurring customer demand.

Established international titanium producers and alternative manufacturing technologies remain relevant competitive considerations.

Risks and What Investors Should Watch

Several uncertainties could affect IperionX's operational development and financial performance.

Manufacturing Ramp-Up: Sustained production requires reliable equipment, process optimisation and consistent product quality.

Customer Qualification: Prototype orders must progress through testing and commercial approval before recurring production volumes can be established.

Government Funding: Reimbursements and future awards depend on programme conditions, government priorities and contractual requirements.

Capital Requirements: Manufacturing expansion and mineral project development may require additional funding.

Technology Commercialisation: GenX has demonstrated promising operating results, but larger-scale economics and performance remain to be established.

Critical Minerals Development: Titan and associated assets remain exposed to permitting, construction, financing and commodity-market risks.

Investors may monitor production capacity, customer orders, government funding developments, further GenX testing and progress on the integrated Titan development strategy.

The Bottom Line

IperionX has progressed from technology development towards an expanding titanium manufacturing operation supported by government programmes and customer qualification activities.

The company's Virginia facility continues ramping production, while prototype programmes are creating opportunities across defence, automotive and industrial markets.

Government funding provides support for the expansion strategy, although reimbursement conditions and capital requirements remain important considerations.

The Titan project adds potential upstream critical minerals exposure, while GenX offers a longer-term pathway for manufacturing efficiency improvements.

The central investment question is whether IperionX can convert technical progress and strategic support into reliable production volumes, recurring commercial revenue and sustainable financial performance.